26.65
price up icon2.35%   0.65
 
loading

Immunovant Inc Azioni (IMVT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
9.92%
127.22
115.74 94.28 80.88 61.55
Income/Loss From Continuing Operations Before Tax
9.78%
-119.70
-109.04 -87.07 -75.09 -51.53
Income Tax Expense/Benefit
1,071%
0.913
0.078 0.077 0.232 -0.108
Income/Loss From Continuing Operations After Tax
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Net Income/Loss
10.53%
-120.61
-109.12 -87.15 -75.32 -51.42
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Diluted Average Shares
16.66%
170.87
146.47 146.09 2.5233 144.52
Basic Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Diluted Earnings Per Share
4.05%
-0.71
-0.74 -0.60 -0.52 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.53
price up icon 0.42%
$98.38
price down icon 0.32%
$31.57
price up icon 0.83%
$93.57
price down icon 0.31%
biotechnology ONC
$300.09
price down icon 5.87%
$196.92
price down icon 1.22%
Capitalizzazione:     |  Volume (24 ore):